ReviewCureus2025
A Comprehensive Literature Review Discussing Diagnostic Challenges of Prinzmetal or Vasospastic Angina.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management.Frontiers in cardiovascular medicine · 2026Review
- Electrocardiogram Diagnosis: ST-Depression With T Wave Inversion in Lead Augmented Vector Left as Harbinger of Inferior ST-Elevation Myocardial Infarction.The Permanente journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review addresses the diagnostic complexities of vasospastic angina (VSA), also known as Prinzmetal angina, by analyzing findings from peer-reviewed studies published over the past decade. It highlights clinical characteristics, guideline-directed approaches, and diagnostic strategies for VSA and ischemia with non-obstructive coronary arteries (INOCA). Although intracoronary provocation testing with acetylcholine or ergonovine remains the gold standard, its use is limited due to procedural variability and restricted access. Non-invasive modalities such as positron emission tomography (PET) imaging, cardiac magnetic resonance imaging (MRI), optical coherence tomography (OCT), and ambulatory electrocardiogram (ECG) monitoring have demonstrated promise but often lack consistency in diagnostic yield. Recent advances, including artificial intelligence (AI)-based ECG interpretation, inflammatory biomarkers, and microRNA profiling, are emerging as tools to improve diagnostic precision and risk stratification. VSA often remains underdiagnosed due to its transient symptoms, resemblance to acute coronary syndromes, and influence of patient factors like age, sex, comorbidities, and symptom variability. Enhancing diagnosis requires standardized testing protocols, broader use of coronary function testing, and integration of novel imaging and biomarker technologies. Recognizing atypical presentations, particularly in younger patients and women, is crucial to reducing misdiagnoses and improving clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.